The relative impact of actual and potential rivalry on firm profitability in the pharmaceutical industry
Karel O. Cool, Lars‐Hendrik Röller, Benoît F. Leleux
Abstract
Karel O. Cool, Lars‐Hendrik Röller, Benoît F. Leleux
Abstract
This paper estimates the effects of actual and potential rivalry on profitability of firms in the U.S. pharmaceutical industry during the 20-year period 1963–82. The results show that during the 1960s actual rivalry among the sampled firms did not materially affect firm profitability, but that during the 1970s competition among incumbents had an increasingly adverse effect on their profitability. The results also show that potential competition significantly reduced drug firms’ profitability during the entire 20-year period. Copyright © 1999 John Wiley & Sons, Ltd.
OpenAlex reports 46 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This paper estimates the effects of actual and potential rivalry on profitability of firms in the U.S. pharmaceutical industry during the 20-year period 1963–82. The results show that during the 1960s actual rivalry among the sampled firms did not materially affect firm profitability, but that during the 1970s competition among incumbents had an increasingly adverse effect on their profitability. The results also show that potential competition significantly reduced drug firms’ profitability during the entire 20-year period. Copyright © 1999 John Wiley & Sons, Ltd.
Key concepts: Rivalry, Profitability index, Competition (biology), Business, Pharmaceutical industry, Industrial organization, Economics, Monetary economics